Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Docusate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Docusate poisoning |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Accidental docusate poisoning |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Intentional docusate poisoning |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
intoxication par le docusate d'intention indéterminée |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Allergy to docusate |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Dioctyl sulfosuccinate overdose |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Accidental dioctyl sulfosuccinate overdose |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Intentional dioctyl sulfosuccinate overdose |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Dioctyl sulfosuccinate overdose of undetermined intent |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Docusate sodium 12.5mg/5mL pediatric oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Docusate sodium 10 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely docusate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Docusate sodium 5 mg/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Docusate sodium 50 mg/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Docusate sodium 120mg micro-enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Docusate adverse reaction |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing docusate sodium and ferrous fumarate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Accidental docusate poisoning |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Intentional docusate poisoning |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing danthron and docusate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing docusate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing docusate sodium and glycerol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Product containing docusate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
|
Allergy to docusate |
Causative agent (attribute) |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely docusate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely docusate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely docusate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Docusate sodium (substance) |
Inferred relationship |
Some |
2 |
Docusate sodium 10 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Docusate sodium 10 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Docusate sodium 5 mg/mL ear drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Docusate sodium 5 mg/mL ear drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Docusate sodium 50 mg/mL ear drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Docusate sodium 50 mg/mL ear drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely docusate sodium 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely docusate sodium 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Docusate sodium (substance) |
Inferred relationship |
Some |
1 |